POV: You're an attendee at the All-In Summit. Three days of main stage conversations with the people shaping business, technology, and society. The All-In Summit returns to LA September 12-14, 2027. Be the first in the room: #AllInSummit# #Meta# #MetaGlasses# #MetaPOV# #POV# @Meta

POV: You're a Bestie attending the All-In Summit. A first-hand experience at the unexpected speaker surprises, immersive partner activations, and showstopping after parties. Be the first in the room for 2027 and apply today when All-In returns to Los Angeles: #AllInSummit# #Meta# #MetaGlasses# #MetaPOV# #POV# @Meta

Past 24hrs in Bittensor: - @IOTA_SN9 kicked off the largest decentralized pipeline-parallel training run to date (16.2B params, 10 stages, 18 replicas) - @theminos_ai co-authored a paper with OpenAI - @engyai got Kimi K3 running on 80 RTX4090s - @metanova_labs announced they're beginning nanobody production in partnership with @Yalotein There is no second best.

Geopolitical conservatism in biotech risks becoming anti-progress. Biosecurity matters but scientific talent is globally distributed and the tools for discovery should be too. @metanova_labs mission is more important than ever. Decentralized, permissionless infrastructure isn't just an ideological position — it's a practical response to a growing problem that ultimately affects all of us. Immigration to the global centers where institutions, capital, and infrastructure are concentrated is harder than ever. At the same time, access to frontier AI is increasingly determined by jurisdiction. As evidenced by @AnthropicAI recent restrictions on Fable and others, the tools that enable scientific discovery are becoming concentrated within a relatively small number of (or single) countries. This has implications for who can contribute to scientific innovation and from where. Roughly 2/3 of Nobel science laureates were not born in the United States, and approximately 40% of U.S. Nobel science prizes awarded since 2000 went to immigrants. Meanwhile, proposals such as a $100k H-1B fee, travel restrictions affecting dozens of countries, and compute export controls under the BIS AI Diffusion Framework are making participation in frontier research increasingly unequal. If similar restrictions had existed throughout the last century, many of the discoveries, companies, and medicines we rely on today may never have emerged. #Bittensor# offers a market-driven alternative for coordinating talent, capital, compute, and scientific innovation across borders.